On 2025-05-13, Iterum Therapeutics PLC (ITRM) announced earnings per share of $-0.14 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.14.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.13 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.14 | $-0.14 |
| 2025-02-07 | 2024-12-31 | $-0.25 | $-0.12 |
| 2024-11-14 | 2024-09-30 | $-0.23 | $-0.30 |
| 2024-08-14 | 2024-06-30 | $-0.52 | $-0.30 |
| 2024-05-13 | 2024-03-31 | $-0.57 | $-0.46 |
| 2024-03-28 | 2023-12-31 | $-1.02 | $-0.94 |
| 2023-11-14 | 2023-09-30 | $-0.91 | $-0.30 |
| 2023-08-11 | 2023-06-30 | $-0.80 | $-0.95 |
| 2023-05-12 | 2023-03-31 | $-0.80 | $-0.78 |
| 2023-03-16 | 2022-12-31 | $-1.22 | $-0.41 |
| 2022-11-10 | 2022-09-30 | $-0.92 | $-0.43 |
| 2022-08-12 | 2022-06-30 | $-0.90 | $-0.45 |
| 2022-05-13 | 2022-03-31 | $-0.60 | $-0.45 |
| 2022-03-28 | 2021-12-31 | -- | $-0.45 |
| 2021-11-12 | 2021-09-30 | $-0.45 | $-0.45 |
| 2021-08-13 | 2021-06-30 | $-0.60 | $-0.60 |
| 2021-05-14 | 2021-03-31 | $-0.60 | $-0.75 |
| 2021-03-12 | 2020-12-31 | $-2.10 | $-1.65 |
| 2020-11-16 | 2020-09-30 | $-6.45 | $-5.10 |
| 2020-08-06 | 2020-06-30 | $-12.29 | $-11.99 |
| 2020-05-14 | 2020-03-31 | $-20.24 | $-13.49 |
| 2020-03-12 | 2019-12-31 | $-27.74 | $-23.84 |
| 2019-11-12 | 2019-09-30 | $-28.04 | $-32.23 |
| 2019-08-14 | 2019-06-30 | $-24.59 | $-28.94 |
| 2019-05-14 | 2019-03-31 | $-22.04 | $-21.59 |
| 2019-03-25 | 2018-12-31 | $-38.23 | $-17.84 |
| 2018-11-14 | 2018-09-30 | $-29.39 | $-18.59 |
| 2018-08-14 | 2018-06-30 | $-19.34 | $-33.28 |